论文部分内容阅读
目的探讨联合检测糖类抗原125(CA125)、糖类抗原199(CA199)及癌胚抗原(CEA)三种肿瘤标志物的血清含量在卵巢癌诊断中的实用价值。方法用电化学发光免疫分析法检测42例卵巢癌患者、34例体检健康者三种肿瘤标志物的血清水平并计算阳性率。结果卵巢癌组三种肿瘤标志物水平显著高于正常对照组(P<0.05)。阳性检出率分别为71.4%、42.9%、19.0%;CA125、CA199二项联合检测阳性率为85.7%;三项同时检测阳性率为90.4%。结论有效的联合检测可提高对卵巢癌诊断的敏感性,有助于卵巢癌的早期诊断和治疗。
Objective To investigate the value of serum levels of three tumor markers, carbohydrate antigen 125 (CA125), carbohydrate antigen 199 (CA199) and carcinoembryonic antigen (CEA) in the diagnosis of ovarian cancer. Methods Electrochemiluminescence immunoassay was used to detect the serum levels of three tumor markers in 42 patients with ovarian cancer and 34 healthy controls and calculate the positive rate. Results The levels of three tumor markers in ovarian cancer group were significantly higher than those in normal control group (P <0.05). The positive rates were 71.4%, 42.9% and 19.0% respectively. The positive rates of CA125 and CA199 were 85.7%. The positive rates of three simultaneous tests were 90.4%. Conclusion Effective joint detection can improve the sensitivity of ovarian cancer diagnosis and contribute to the early diagnosis and treatment of ovarian cancer.